Insider · CIK 0001196632
Richard S Lindahl
cfoofficerdirector
Files at EBS (Emergent BioSolutions Inc.), CMPX (Compass Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 8, 2025 | EBS Emergent BioSolutions Inc. | FTax withholding Common Stock | -2,733 | $6.63 | $18k | 296,492 | Jun 10, 2025 |
| Mar 6, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +146,888 | $0.00 | $0 | 299,225 | Mar 10, 2025 |
| Mar 6, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Employee Stock Options (Right to Buy)derivative | +178,546 | $0.00 | $0 | 484,490 | Mar 10, 2025 |
| Feb 12, 2025 | EBS Emergent BioSolutions Inc. | DDisposition to issuer Common Stock | -16,916 | $0.00 | $0 | 154,093 | Mar 4, 2025 |
| Feb 28, 2025 | EBS Emergent BioSolutions Inc. | FTax withholding Common Stock | -1,073 | $7.48 | $8,026 | 153,020 | Mar 4, 2025 |
| Mar 1, 2025 | EBS Emergent BioSolutions Inc. | FTax withholding Common Stock | -683 | $7.48 | $5,109 | 152,337 | Mar 4, 2025 |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 13, 2025 |
| Oct 15, 2024 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 171,009 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.